| |
|
| |
|
| |
|
| |
FDA Releases Guidance on Opioids
In their effort to help industry develop abuse-deterrent opioids, FDA has released Guidance for Industry: Abuse-Deterrent Opioids—Evaluation and Labeling, Draft Guidance. More... |
|
| |
|
| |
Is the Pharma Industry Using Social Media Effectively?
For the pharmaceutical industry, social media poses concerns that range from release of propriety information to regulatory constraints to patient safety, which have limited the industry’s use of this new potential marketing and networking tool. More... |
| |
Industry Briefs
In other news, Agensys has opened a new R&D facility in California, Almac is expanding its drug-product pharmaceutical-development services, and Biotest Pharmaceuticals has entered into a long-term manufacturing, supply and license agreement with ADMA Biologics. More... |
|
|
| Agilent |
Together: It's how we work. It's how we help Pharma Succeed.
Look to Agilent for real world solutions that help pharmaceutical companies discover more rapidly and more efficiently.
The Agilent RapidFire High-throughput System and 6550 iFunnel Q-TOF mass spec helped one lab reduce a week of work to 4.5 hours, transforming their productivity. Discover more, and request your free ADME Solutions Guide at our new pharma web page www.agilent.com/chem/togetherADME |
 |
|
| Shimadzu |
Three new triple quads achieve a new global standard in mass spectrometry
Three new triple quadrupole mass spectrometers LCMS-8040, LCMS-8080 and GCMS-TQ8030 complete Shimadzu’s UFMS series consisting of seven powerful systems. The UFMS product family provides higher sensitivity, greater excellence in data quality, increased analytical throughput and a wider range of applications.  Read more: |
 |
|
| |
| Flexicon Liquid Filling |
Fully automatic aseptic liquid filling system
The FPC50W is an aseptic filling system with full or partial stoppering and crimp capping of vials, delivering fill volumes ranging 0.1ml to 100ml and filling accuracy of ± 0.5%.
 Read more |
 |
|
|
|
| Pharmapack Europe |
13-14 February 2013, Grande Halle de la Villette, Paris, France
How Innovations in Pharma Packaging and Drug Delivery Technologies Enhance Patient Safety and Compliance.  Read more
|
 |
|
|
|
|
|
| What area do you think will see increased regulatory attention and enforcement in 2013? |
|
Foreign APIs |
32% |
| |
|
GMP inspections |
19% |
| |
|
|
|
Manufacturing processes |
13% |
| |
|
|
|
Counterfeit medicines |
28% |
| |
|
|
|
Social media and digital marketing |
8% |
| |
|
|
|
Biosimilars and generics |
36% |
This week we would like to know...
Which of the following has had the most significant advances in PAT over the last 5 years?
|
|
|
| Contact Us |
Click here to contact editorial.
Click here to contact sales. |
|
